Table of Contents Section 1 Secondary Progressive Multiple Sclerosis Drug Product Definition Section 2 Global Secondary Progressive Multiple Sclerosis Drug Market Manufacturer Share and Market Overview 2.1 Global Manufacturer Secondary Progressive Multiple Sclerosis Drug Shipments 2.2 Global Manufacturer Secondary Progressive Multiple Sclerosis Drug Business Revenue 2.3 Global Secondary Progressive Multiple Sclerosis Drug Market Overview Section 3 Manufacturer Secondary Progressive Multiple Sclerosis Drug Business Introduction 3.1 AB Science SA Secondary Progressive Multiple Sclerosis Drug Business Introduction 3.1.1 AB Science SA Secondary Progressive Multiple Sclerosis Drug Shipments, Price, Revenue and Gross profit 2014-2018 3.1.2 AB Science SA Secondary Progressive Multiple Sclerosis Drug Business Distribution by Region 3.1.3 AB Science SA Interview Record 3.1.4 AB Science SA Secondary Progressive Multiple Sclerosis Drug Business Profile 3.1.5 AB Science SA Secondary Progressive Multiple Sclerosis Drug Product Specification 3.2 Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Business Introduction 3.2.1 Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Shipments, Price, Revenue and Gross profit 2014-2018 3.2.2 Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Business Distribution by Region 3.2.3 Interview Record 3.2.4 Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Business Overview 3.2.5 Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Product Specification 3.3 Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Business Introduction 3.3.1 Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Shipments, Price, Revenue and Gross profit 2014-2018 3.3.2 Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Business Distribution by Region 3.3.3 Interview Record 3.3.4 Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Business Overview 3.3.5 Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Product Specification 3.4 F. Hoffmann-La Roche Ltd. Secondary Progressive Multiple Sclerosis Drug Business Introduction 3.5 Genzyme Corporation Secondary Progressive Multiple Sclerosis Drug Business Introduction 3.6 Glialogix, Inc. Secondary Progressive Multiple Sclerosis Drug Business Introduction … Section 4 Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Region Level) 4.1 North America Country 4.1.1 United States Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.1.2 Canada Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.2 South America Country 4.2.1 South America Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.3 Asia Country 4.3.1 China Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.3.2 Japan Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.3.3 India Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.3.4 Korea Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.4 Europe Country 4.4.1 Germany Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.4.2 UK Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.4.3 France Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.4.4 Italy Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.4.5 Europe Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.5 Other Country and Region 4.5.1 Middle East Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.5.2 Africa Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.5.3 GCC Secondary Progressive Multiple Sclerosis Drug Market Size and Price Analysis 2014-2018 4.6 Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Region Level) Analysis 2014-2018 4.7 Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Region Level) Analysis Section 5 Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Product Type Level) 5.1 Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Product Type Level) Market Size 2014-2018 5.2 Different Secondary Progressive Multiple Sclerosis Drug Product Type Price 2014-2018 5.3 Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Product Type Level) Analysis Section 6 Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Industry Level) 6.1 Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Industry Level) Market Size 2014-2018 6.2 Different Industry Price 2014-2018 6.3 Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Industry Level) Analysis Section 7 Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Channel Level) 7.1 Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Channel Level) Sales Volume and Share 2014-2018 7.2 Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Channel Level) Analysis Section 8 Secondary Progressive Multiple Sclerosis Drug Market Forecast 2018-2023 8.1 Secondary Progressive Multiple Sclerosis Drug Segmentation Market Forecast (Region Level) 8.2 Secondary Progressive Multiple Sclerosis Drug Segmentation Market Forecast (Product Type Level) 8.3 Secondary Progressive Multiple Sclerosis Drug Segmentation Market Forecast (Industry Level) 8.4 Secondary Progressive Multiple Sclerosis Drug Segmentation Market Forecast (Channel Level) Section 9 Secondary Progressive Multiple Sclerosis Drug Segmentation Product Type 9.1 Inebilizumab Product Introduction 9.2 GLX-1112 Product Introduction 9.3 DC-TAB Product Introduction 9.4 Etomoxir Product Introduction 9.5 IB-MS Product Introduction Section 10 Secondary Progressive Multiple Sclerosis Drug Segmentation Industry 10.1 Hospital Clients 10.2 Clinic Clients Section 11 Secondary Progressive Multiple Sclerosis Drug Cost of Production Analysis 11.1 Raw Material Cost Analysis 11.2 Technology Cost Analysis 11.3 Labor Cost Analysis 11.4 Cost Overview Section 12 Conclusion Chart and Figure Figure Secondary Progressive Multiple Sclerosis Drug Product Picture from AB Science SA Chart 2014-2018 Global Manufacturer Secondary Progressive Multiple Sclerosis Drug Shipments (Units) Chart 2014-2018 Global Manufacturer Secondary Progressive Multiple Sclerosis Drug Shipments Share Chart 2014-2018 Global Manufacturer Secondary Progressive Multiple Sclerosis Drug Business Revenue (Million USD) Chart 2014-2018 Global Manufacturer Secondary Progressive Multiple Sclerosis Drug Business Revenue Share Chart AB Science SA Secondary Progressive Multiple Sclerosis Drug Shipments, Price, Revenue and Gross profit 2014-2018 Chart AB Science SA Secondary Progressive Multiple Sclerosis Drug Business Distribution Chart AB Science SA Interview Record (Partly) Figure AB Science SA Secondary Progressive Multiple Sclerosis Drug Product Picture Chart AB Science SA Secondary Progressive Multiple Sclerosis Drug Business Profile Table AB Science SA Secondary Progressive Multiple Sclerosis Drug Product Specification Chart Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Shipments, Price, Revenue and Gross profit 2014-2018 Chart Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Business Distribution Chart Actelion Ltd Interview Record (Partly) Figure Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Product Picture Chart Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Business Overview Table Actelion Ltd Secondary Progressive Multiple Sclerosis Drug Product Specification Chart Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Shipments, Price, Revenue and Gross profit 2014-2018 Chart Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Business Distribution Chart Biogen, Inc. Interview Record (Partly) Figure Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Product Picture Chart Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Business Overview Table Biogen, Inc. Secondary Progressive Multiple Sclerosis Drug Product Specification 3.4 F. Hoffmann-La Roche Ltd. Secondary Progressive Multiple Sclerosis Drug Business Introduction … Chart United States Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart United States Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart Canada Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart Canada Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart South America Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart South America Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart China Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart China Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart Japan Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart Japan Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart India Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart India Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart Korea Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart Korea Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart Germany Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart Germany Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart UK Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart UK Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart France Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart France Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart Italy Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart Italy Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart Europe Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart Europe Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart Middle East Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart Middle East Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart Africa Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart Africa Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart GCC Secondary Progressive Multiple Sclerosis Drug Sales Volume (Units) and Market Size (Million $) 2014-2018 Chart GCC Secondary Progressive Multiple Sclerosis Drug Sales Price ($/Unit) 2014-2018 Chart Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Region Level) Sales Volume 2014-2018 Chart Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Region Level) Market size 2014-2018 Chart Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Product Type Level) Volume (Units) 2014-2018 Chart Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Product Type Level) Market Size (Million $) 2014-2018 Chart Different Secondary Progressive Multiple Sclerosis Drug Product Type Price ($/Unit) 2014-2018 Chart Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Industry Level) Market Size (Volume) 2014-2018 Chart Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Industry Level) Market Size (Share) 2014-2018 Chart Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Industry Level) Market Size (Value) 2014-2018 Chart Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Channel Level) Sales Volume (Units) 2014-2018 Chart Global Secondary Progressive Multiple Sclerosis Drug Market Segmentation (Channel Level) Share 2014-2018 Chart Secondary Progressive Multiple Sclerosis Drug Segmentation Market Forecast (Region Level) 2018-2023 Chart Secondary Progressive Multiple Sclerosis Drug Segmentation Market Forecast (Product Type Level) 2018-2023 Chart Secondary Progressive Multiple Sclerosis Drug Segmentation Market Forecast (Industry Level) 2018-2023 Chart Secondary Progressive Multiple Sclerosis Drug Segmentation Market Forecast (Channel Level) 2018-2023 Chart Inebilizumab Product Figure Chart Inebilizumab Product Advantage and Disadvantage Comparison Chart GLX-1112 Product Figure Chart GLX-1112 Product Advantage and Disadvantage Comparison Chart DC-TAB Product Figure Chart DC-TAB Product Advantage and Disadvantage Comparison Chart Etomoxir Product Figure Chart Etomoxir Product Advantage and Disadvantage Comparison Chart IB-MS Product Figure Chart IB-MS Product Advantage and Disadvantage Comparison Chart Hospital Clients Chart Clinic Clients